Pep-Therapy has now raised $2.9m to deliver peptide-based cancer drugs that further research from Université Pierre et Marie Curie, Institut Curie and Inserm.

The Columbia University spinout has received cash from the investment arms of Samsung, Verizon and R/GA.

The Public University of Navarre spinout will use the funds to prepare clinical trials of its biomarker-based asthma diagnosis device.

Anfiro, which has licensed Purdue and Notre Dame research, aims to complete a prototype of its polymer-based water treatment system by 2018.

The cash will help the company develop technology that allows machines to learn new tasks after they have received instructions through a virtual reality headset.

Chromosol is commercialising optical amplifiers for semiconductors that transmit data via light pulses rather than as electrical signals.

The Unilever-backed augmented reality game developer has secured $5.8m to grow its presence in the UK and expand internationally.